Skip to main content
×
Home
    • Aa
    • Aa

Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux

  • M Masaany (a1), M B Marina (a2), W P Sharifa Ezat (a3) and A Sani (a2)
Abstract
AbstractObjective:

To determine the sensitivity and specificity of intensive empirical treatment with pantoprazole in diagnosing laryngopharyngeal reflux in adults.

Study design:

This was a prospective, double-blind study.

Subjects and methods:

Fifty-five patients with either a Reflux Symptom Index of more than 13 or a Reflux Finding Score of more than 7 were enrolled. All patients underwent 24-hour, double-probe pH monitoring before commencing pantoprazole 40 mg twice daily; both investigators and patients were blinded to pH monitoring results. The Reflux Symptom Index and Reflux Finding Score were reassessed during the second, third and fourth month of follow up.

Results:

The sensitivity of empirical pantoprazole treatment in diagnosing laryngopharyngeal reflux was 92.5 per cent. The specificity was 14.2 per cent, the positive predictive value 86 per cent and the negative predictive value 25 per cent. There was significant reduction in the total Reflux Symptom Index and Reflux Finding Score after the second, third and fourth month of treatment. There was no correlation between laryngopharyngeal reflux and body mass index.

Conclusion:

Our results suggest that intensive empirical treatment with proton pump inhibitors is effective in diagnosing laryngopharyngeal reflux.

Copyright
Corresponding author
Address for correspondence: Dr Masaany Mansor, Department of ORL-HNS, Hospital Sultanah Bahiyah, 05460, Alor Setar, Malaysia Fax: 604 7407335 E-mail: masaanymansor@yahoo.com
References
Hide All
1Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101(4 Pt 2 Suppl 53):178
2Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL. The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope 2004;114:670–4
3Fraser AG. Gastroesophageal reflux and laryngeal symptoms. Aliment Pharmacol Ther 1994;8:265–72
4Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002;16:274–7
5Qadeer MA, Swoger J, Milstein C, Hicks DM, Ponsky J, Richter JE et al. Correlation between symptom and laryngeal signs in laryngopharyngeal reflux. Laryngoscope 2005;115:1947–52
6Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;111:1313–17
7Hickson C, Simpson CB, Falcon R. Laryngeal pseudosulcus as a predictor of laryngopharyngeal reflux. Laryngoscope 2001;111:1742–5
8Dobhan R, Castell DO. Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol 1993;88:25–9
9Panetti M, Pearson JP, Dettmar PW, Koufman JA. Active pepsin in airway secretions: possible evidence for new supraesophageal pH criteria. Gut 2001;120:A118–A119
10Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmstead County, Minnesota. Gastroenterology 1997;112:1448–56
11Metz DC, Childs ML, Ruiz C, Weinstein GS. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg 1997;116:41–6
12Habermann W, Kiesler K, Eherer A, Friedrich G. Short-term therapeutic trial of proton pump inhibitors in suspected extraesophageal reflux. J Voice 2002;16:425–32
13Belafsky PC, Rees CJ. Identifying and managing laryngopharyngeal reflux. Hosp Physician 2007;27:1520
14Brett S. Science review: the use of proton pump inhibitors for gastric acid suppression in critical illness. Crit Care 2005;9:4550
15Goh KL, Benamouzig R, Sander P, Schwan T. Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial – the EMANCIPATE study. Eur J Gastroenterol Hepatol 2007;19:205–11
16Ho K, Spence J, Murphy MF. Review of pain-measurement tools. Ann Emerg Med 1996;27:427–32
17Lam P, Wei WI, Hui Y, How K. Prevalence of pH-documented laryngopharyngeal reflux in Chinese patients with clinically suspected reflux laryngitis. Am J Otolaryngol 2006;27:186–9
18Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000;123:385–8
19Pan GZ, Xu GM, Ke MY, Han SM, Guo HP, Li ZS et al. Epidemiological study of symptomatic gastroesophageal reflux disease in China: Beijing and Shanghai. Chinese Journal of Digestive Diseases 2000;1:28
20Goh KL, Chang CS, Fock KM, Ke M, Park HJ, Lam SK. Gastro-oesophageal reflux disease in Asia. J Gastroenterol Hepatol 2000;15:230–8
21Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol. 2003;98:1487–93
22Ho KY, Lee HJ, Wong WY. Curry promotes significant acid reflux in patients with gastroesophageal reflux disease. J Gastroenterol Hepatol 2001;16(Suppl):A112
23Gasiorowska A, Fass R. The proton pump inhibitor (PPI) test in GERD: does it still have a role? J Clin Gastroenterol 2008;42:867–74
24Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist H et al. Heartburn without esophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997;32:974–9
25Park W, Hicks DM, Khandala F, Richter JE, Abelson TI, Milstein C et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005;115:1230–8
26Belafsky PC, Postma GN, Koufman JA. Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope 2001;111:979–81
27Ruhl CE, Everhart JE. Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I epidemiologic follow-up study. First National Health and Nutrition Examination Survey. Ann Epidemiol 1999;9:424–5
28Halum SL, Postma GN, Johnston C, Belafsky PC, Koufman JA. Patients with isolated laryngopharyngeal reflux are not obese. Laryngoscope 2005;115:1042–5
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 2
Total number of PDF views: 10 *
Loading metrics...

Abstract views

Total abstract views: 110 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st October 2017. This data will be updated every 24 hours.